 |
 |
|
|
|
| Letrozole |
 |
| Femera 99%, Powder |
 |
| 112809-51-5 |
 |
| Letrozole is primarily administered to halt the progression of breast cancer in women. It is generally used as part of an aggressive treatment in post-menopausal women, to fight and reverse the spread of breast cancer after other treatments (such as Tamoxifen therapy) has failed. Its probably the most efficient product on the market for this purpose. Letrozole is very similar in both structure and action to its AI predecessor Arimidex. |
 |
Letrozole (Femera)
Synonym: femara
CAS: 112809-51-5
Assay: 98.0-102.0%.
Packing: 1Kg/foil bag
Delivery: Courier.
MF: C17H11N5
MW: 285.3
MP: 181-183C
Character: White crystalline powder.
Skype:lee.liangqing1
Email: david@pharmade.com
Please contact me if you have any interests. |
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
